Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Category list : Safety warnings

Sort by: Newest first Oldest first A-Z Z-A

  • Zoledronic acid 'patient card' would reduce risk of bone tissue death Subscription

    16 MAR 2015 14:35

    Use of a patient reminder card has been recommended by a committee of the European Medicines Agency to minimise the risk of jaw osteonecrosis associated with zoledronic acid.

  • NHS staff who have blown the whistle suffer victimisation, loss of employment and personal and family breakdown, recent study finds

    Blowing the whistle on whistleblowing Subscription

    19 FEB 2015 14:16

    Concerns raised about standards of care should be taken seriously, but healthcare workers are still worried about the repercussions of speaking up.

  • The European Medicines Agency’s (EMA’s) Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that hydroxyzine is associated with a “small but definite risk” of serious heart rhythm anomalies

    Hydroxyzine safety measures loom after heart risk review Subscription

    17 FEB 2015 11:45 By Bernard Murphy

    The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee has confirmed that hydroxyzine is associated with a “small but definite risk” of serious heart rhythm anomalies.

  • Medicines regulator warns over unlicensed blood plasma product Subscription

    4 FEB 2015 9:58

    An unlicensed medicine sold via European websites and which claims to treat HIV, cancer and autism, contains blood plasma never intended for human use.

  • Diclofenac withdrawn from over-the-counter (OTC) sales in UK pharmacies due to concerns about cardiovascular safety

    Is it time to rethink the place of oral diclofenac? Subscription

    21 JAN 2015 17:45
    Comments (2)

    In light of the withdrawal of diclofenac from OTC sale in UK pharmacies over concerns about cardiovascular safety, it may be time to reconsider the role of the drug altogether.

  • Diabetes pump warning Subscription

    16 JAN 2015 15:57

    The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a safety warning for the Accu-Chek Spirit Combo insulin infusion pumps manufactured by Roche Diagnostics. Interrupting the pump’s power, to change the battery or example, may reset the default date and time. If this change goes unnoticed, and the user confirms the default settings, there will be a shift in the basal rate time block and this may affect insulin delivery. Patients with impaired ...

  • Recall of Ebixa Subscription

    19 DEC 2014 15:29

    The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for specific batches of Ebixa (memantine hydrochloride; Lundbeck) 5mg/pump actuation 50ml and 100ml bottle. This is because of a fault with some of the pump devices which may result in suboptimal dosage of the product. Further information is available on the MHRA website.

  • Initial Fluad investigations find no manufacturing defect Subscription

    3 DEC 2014 16:03

    Preliminary investigations have found no manufacturing defect in the influenza vaccine Fluad, which has been linked to the deaths of 13 older people in Italy.

  • Management of whistleblowers in the healthcare sector

    Creating a culture of whistleblowing for pharmacists Subscription

    13 OCT 2014 17:41 By Ingrid Torjesen

    How do we improve the treatment of whistleblowers in the healthcare sector?

  • Traffic jam in the M25, UK

    Driving after taking drugs and medicines Subscription

    16 SEP 2014 By Katie Perkins

    Find out how new drug driving rules coming into force from March 2015 will affect your patients.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.